Literature DB >> 8875474

Embolization of cerebral arteriovenous malformations: Part I--Technique, morphology, and complications.

G Wikholm1, C Lundqvist, P Svendsen.   

Abstract

OBJECTIVE: The aim of this two-part study is to give a full account of all patients referred for embolization of arteriovenous malformations (AVMs) from 1987 to 1993. This article (Part I of II) presents the patient study, including angiographic features and their relation to the immediate outcome of embolization.
METHODS: Of the 192 patients referred, 150 were subsequently treated. Most patients were referred by neurosurgeons, and 85% of the AVMs were Spetzler-Martin Grade > or = 3. We have accounted for the 42 patients who did not undergo embolization.
RESULTS: Occlusion from embolization alone (total embolization) was obtained in 13% of patients. Full treatment (total embolization or embolization and then stereotactic radiation or surgery) was achieved in two-thirds of all patients (n = 100, 66%), and combined treatment with stereotactic gamma radiation was the most important part of the treatment strategy. The procedural mortality was 1.3%. The total incidence of complications after embolization was high (40%), but only 6.7% of cases were labeled severe. Of all angiographic features that were considered, large size and the presence of deep feeders were predictors of failure to achieve full treatment. Thirty-four patients with AVMs < 8 cc were included in the study. These could have been irradiated as the sole treatment. In this group of small AVMs, the results of embolization were far better than in the whole group. Fourteen of the AVMs had volumes of < 4 cc, and 10 of these (71%) were totally embolized. One patient had a hemianopsia. Among AVMs 4 to 8 cc in volume (n = 20), the total embolization rate was 15%, the full treatment rate in combination with gamma treatment was 75%, and 10% of the patients were operated on after embolization. Severe complications occurred in 15% of patients, but no complications occurred after November 1990.
CONCLUSION: In a series of AVMs, most of which were regarded as unsuitable for surgical excision, two-thirds were reduced to a size suitable for gamma knife treatment or totally occluded by embolization alone. The total complication rate was high, but the combined rate of death and complications affecting lifestyle was 8.0%, equal to approximately 3.2 years of natural history.

Entities:  

Mesh:

Year:  1996        PMID: 8875474     DOI: 10.1097/00006123-199609000-00004

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  24 in total

1.  Endovascular Treatment of Cerebral AVM: Our Experience with Onyx.

Authors:  A Pérez-Higueras; R Rossi López; D Quiñones Tapia
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

2.  Combined effects of embolization and hypofractionated conformal stereotactic radiotherapy in arteriovenous malformations of the brain.

Authors:  P Lindvall; G Wikholm; P Bergström; P Löfroth; A T Bergenheim
Journal:  Interv Neuroradiol       Date:  2005-10-26       Impact factor: 1.610

3.  Endovascular treatment of intracerebral arteriovenous malformations: procedural safety, complications, and results evaluated by MR imaging, including diffusion and perfusion imaging.

Authors:  M Cronqvist; R Wirestam; B Ramgren; L Brandt; B Romner; O Nilsson; H Säveland; S Holtås; E-M Larsson
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

4.  Acute and chronic swine rete arteriovenous malformation models: effect of ethiodol and glacial acetic acid on penetration, dispersion, and injection force of N-butyl 2-cyanoacrylate.

Authors:  B B Lieber; A K Wakhloo; R Siekmann; M J Gounis
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

5.  Acute and chronic swine rete arteriovenous malformation models: hemodynamics and vascular remodeling.

Authors:  A K Wakhloo; B B Lieber; R Siekmann; D J Eber; M J Gounis
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

6.  Quantitative assessment of polymerization-binding mechanics of cyanoacrylates: model development and validation.

Authors:  Purushothaman Kailasnath; John C Chaloupka
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

7.  A contribution to the controversy over dimethyl sulfoxide toxicity: anesthesia monitoring results in patients treated with Onyx embolization for intracranial aneurysms.

Authors:  A G Pamuk; I Saatci; H S Cekirge; U Aypar
Journal:  Neuroradiology       Date:  2005-05-03       Impact factor: 2.804

8.  Europium fluorescence to visualize N-butyl 2-cyanoacrylate in embolized vessels of an arteriovenous malformation swine model.

Authors:  W J Calvo; B B Lieber; L N Hopkins; A K Wakhloo
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

9.  Ventricular/paraventricular small arteriovenous malformations: role of embolisation with cyanoacrylate.

Authors:  Ismail Oran; Mustafa Parildar; Abdurrahim Derbent
Journal:  Neuroradiology       Date:  2005-04-02       Impact factor: 2.804

10.  Transvenous embolization of a ruptured deep cerebral arteriovenous malformation. A technical note.

Authors:  V M Pereira; A Marcos-Gonzalez; I Radovanovic; P Bijlenga; A P Narata; J Moret; K Schaller; K O Lovblad
Journal:  Interv Neuroradiol       Date:  2013-03-04       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.